These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18631772)

  • 1. Current and future therapeutic approaches in progressive supranuclear palsy.
    van Balken I; Litvan I
    Handb Clin Neurol; 2008; 89():493-508. PubMed ID: 18631772
    [No Abstract]   [Full Text] [Related]  

  • 2. Peduncolopontine nucleus stimulation in progressive supranuclear palsy: a randomised trial.
    Scelzo E; Lozano AM; Hamani C; Poon YY; Aldakheel A; Zadikoff C; Lang AE; Moro E
    J Neurol Neurosurg Psychiatry; 2017 Jul; 88(7):613-616. PubMed ID: 28214797
    [No Abstract]   [Full Text] [Related]  

  • 3. Toward future therapies in progressive supranuclear palsy.
    Burn DJ; Warren NM
    Mov Disord; 2005 Aug; 20 Suppl 12():S92-8. PubMed ID: 16092097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep brain stimulation of the pedunculopontine nucleus for treatment of gait and balance disorder in progressive supranuclear palsy: Effects of frequency modulations and clinical outcome.
    Galazky I; Kaufmann J; Lorenzl S; Ebersbach G; Gandor F; Zaehle T; Specht S; Stallforth S; Sobieray U; Wirkus E; Casjens F; Heinze HJ; Kupsch A; Voges J
    Parkinsonism Relat Disord; 2018 May; 50():81-86. PubMed ID: 29503154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive Supranuclear Palsy: an Update.
    Armstrong MJ
    Curr Neurol Neurosci Rep; 2018 Feb; 18(3):12. PubMed ID: 29455271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peduncolopontine DBS improves balance in progressive supranuclear palsy: Instrumental analysis.
    de Oliveira Souza C; de Lima-Pardini AC; Coelho DB; Brant Machado R; Alho EJL; Di Lorenzo Alho AT; Teixeira LA; Teixeira MJ; Barbosa ER; Fonoff ET
    Clin Neurophysiol; 2016 Nov; 127(11):3470-3471. PubMed ID: 27721105
    [No Abstract]   [Full Text] [Related]  

  • 7. Initial experience with electroconvulsive therapy for progressive supranuclear palsy.
    Hauser RA; Trehan R
    Mov Disord; 1994 Jul; 9(4):467-9. PubMed ID: 7969219
    [No Abstract]   [Full Text] [Related]  

  • 8. An interview with Philip G. Janicak, MD: Neuromodulation by Norman Sussman, MD.
    Janicak PG
    CNS Spectr; 2008 May; 13(5):370-4. PubMed ID: 18543409
    [No Abstract]   [Full Text] [Related]  

  • 9. Subthalamic stimulation improves levodopa responsive symptoms in a case of progressive supranuclear palsy.
    Bergmann KJ; Salak VL
    Parkinsonism Relat Disord; 2008; 14(4):348-52. PubMed ID: 17825599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantation of the nucleus tegmenti pedunculopontini in a PSP-P patient: safe procedure, modest benefits.
    Brusa L; Iani C; Ceravolo R; Galati S; Moschella V; Marzetti F; Stanzione P; Stefani A
    Mov Disord; 2009 Oct; 24(13):2020-2. PubMed ID: 19672983
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment resistant depression: therapy and novel neuromodulatory treatments].
    Kosel M; Berney A
    Rev Med Suisse; 2012 May; 8(339):942-5. PubMed ID: 22675825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on the paper by Doshi et al. Entitled 'bilateral pedunculopontine nucleus stimulation for progressive supranuclear palsy'.
    Kondziolka D
    Stereotact Funct Neurosurg; 2015; 93(1):66. PubMed ID: 25659372
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathological study in progressive supranuclear palsy with pedunculopontine stimulation.
    Hazrati LN; Wong JC; Hamani C; Lozano AM; Poon YY; Dostrovsky JO; Hutchison WD; Zadikoff C; Moro E
    Mov Disord; 2012 Sep; 27(10):1304-7. PubMed ID: 22865554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of STN/SNr deep brain stimulation in a case of progressive supranuclear palsy with a Parkinson disease phenotype.
    Shepherd CE; Lewis SJG; Tisch S; McCann H; Jonker B; Halliday GM
    J Neuropathol Exp Neurol; 2023 Aug; 82(9):821-823. PubMed ID: 37418010
    [No Abstract]   [Full Text] [Related]  

  • 15. Brain stimulation techniques in the treatment of obsessive-compulsive disorder: current and future directions.
    Dell'Osso B; Altamura AC; Allen A; Hollander E
    CNS Spectr; 2005 Dec; 10(12):966-79, 983. PubMed ID: 16344833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy.
    Moccia M; Picillo M; Erro R; Allocca R; Barone P; Vitale C
    J Neurol Sci; 2015 Mar; 350(1-2):103-4. PubMed ID: 25697711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Will electroconvulsive therapy disappear in the near future?].
    Motohashi N
    Seishin Shinkeigaku Zasshi; 2012; 114(10):1208-15. PubMed ID: 23234202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive supranuclear palsy: anatomoclinical and biochemical considerations.
    Agid Y; Javoy-Agid F; Ruberg M; Pillon B; Dubois B; Duyckaerts C; Hauw JJ; Baron JC; Scatton B
    Adv Neurol; 1987; 45():191-206. PubMed ID: 2881445
    [No Abstract]   [Full Text] [Related]  

  • 19. 3rd European Conference on brain stimulation in psychiatry - From mechanism to medicine.
    Brunelin J; Mondino M; Arns M; Baeken C; Brem AK; Filipčić I; Ganho-Avila A; Palm U; Poleszczyk A; Sauvaget A; O'Shea J; D'Urso G; Poulet E
    Encephale; 2019 Jun; 45 Suppl 2():S47-S49. PubMed ID: 31104764
    [No Abstract]   [Full Text] [Related]  

  • 20. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.